{
  "meta": {
    "title": "Ckd",
    "url": "https://brainandscalpel.vercel.app/ckd-124ddde9.html",
    "scrapedAt": "2025-11-30T11:12:46.512Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous urogram</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Commence on an Angiotensin Receptor Blocker</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Better glycaemic control</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Consider an islet cell transplant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man with type 1 diabetes attends a follow-up appointment in the diabetic clinic. He has a blood pressure of 145/86 mmHg. There is no evidence of diabetic retinopathy or neuropathy. He has an elevated albumin: creatinine ratio in his urine. Creatinine is 1.01 mg/dl. Which of the following should be done?</span></p>",
      "unique_key": "DT1197796",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This is likely<strong> early diabetic nephropathy.</strong> The first sign is<strong> microalbuminuria</strong>, even when creatinine is normal.</p>\n<ul>\n<li>The patient has a raised albumin: creatinine ratio in the urine.</li>\n<li>The early morning<strong> albumin-to-creatinine ratio (ACR)</strong> is a substitute for 24-hour urine protein estimation.</li>\n<li>An ACR of 30-300 mg/g indicates <strong>microalbuminuria</strong>, and &gt;300 mg/g indicates <strong>macroalbuminuria</strong>, correlating with proteinuria levels.</li>\n<li>The given patient is a<strong> Type I diabetic</strong>. It has not been mentioned whether his blood sugars are controlled or not. His BP is 145/86mmHg, which is above the target recommended for diabetics by JNC8 guidelines (Goal is &lt;140/90 mmHg). Also, he has a high AC ratio, indicative of</li>\n<li>The presence of proteinuria indicates that the patient will develop a decline in GFR. So we aim to retard the progression of the disease. </li>\n<li>In <strong>Type I diabetes</strong>, strict control of blood sugars has been shown to prevent the development or retard the progression of proteinuria.</li>\n<li>In <strong>Type 2 diabetes</strong>, strict glycemic control can reduce the risk of developing microalbuminuria and slow early nephropathy progression, but its benefit diminishes once significant proteinuria is established.</li>\n<li>In our patient it has not been mentioned about his glycemic status. But his blood pressure is not controlled.</li>\n<li><strong>ACE inhibitors or ARBs</strong> are first-line treatments to retard the progression of diabetic nephropathy by reducing intraglomerular pressure and proteinuria, and they also help control blood pressure.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Intravenous urogram (Option A): </strong>This is a radiological procedure used to assess structural abnormalities in the urinary tract (e.g., obstruction, stones, masses). It is not indicated in a patient with early diabetic nephropathy, which is a functional glomerular disease.</p>\n<p><strong>Better glycaemic control (Option C): </strong>This is important long-term to prevent progression of diabetic nephropathy. However, the first-line, most evidence-based intervention for albuminuria is to start an ACE inhibitor or ARB, regardless of glycemic control.</p>\n<p><strong>Consider an islet cell transplant (Option D):</strong> This is reserved for patients with Brittle diabetes, Severe hypoglycemia unawareness, and patients already requiring kidney transplantation due to end-stage diabetic nephropathy</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal size of 7 cm</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hb of 12 g/dl</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure of 160/90</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of proteinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old lady has been noted for the first time to have renal impairment. Which of the following features is most useful in determining whether the renal failure is acute or chronic?</span></p>",
      "unique_key": "DT1197809",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197809,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical clues to <strong>chronicity of renal impairment </strong>are symptoms of azotemia for &gt; 3 months, renal osteodystrophy, bilaterally scarred kidneys, and broad casts in urinary sediments.</li>\n<li>Ultrasonically, the normal size of kidneys is<strong> 10-12 cms</strong>. <strong>Kidneys &lt; 8 cm</strong> with destroyed parenchyma and increased echogenicity are seen in CKD.</li>\n<li><strong>Renal osteodystrophy </strong>and a<strong> small-sized kidney </strong>with destroyed renal parenchyma, characterised by increased echogenicity and a thinned-out cortex, along with isosthenuria and broad casts, are the only conclusive findings of chronicity.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917cae727b5-1e4b-43c4-984d-03005dacbe9a.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Haemoglobin of 12 g/dl (Option B) </strong>is only mildly reduced and can be seen in both AKI and CKD, or even in non-renal conditions, making it less specific for determining chronicity compared to small renal size.</p>\n<p><strong>Blood pressure of 160/90 (Option C):</strong> Hypertension can be a consequence of CKD, but it is not specific to CKD; It may be a primary disorder itself contributing to CKD</p>\n<p><strong>Presence of proteinuria (Option D): </strong>Proteinuria can be present in several acute as well as chronic conditions. E.g., vigorous exercise, acute tubulointerstitial disease, nephritic syndrome, etc<br /> </p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic nephropathy</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic interstitial nephritis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal calculi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old lady was diagnosed with type 2 diabetes a year ago. Since the diagnosis was made, she was found to have pre-proliferative diabetic retinopathy. She has a history of rheumatoid arthritis and has been taking ibuprofen regularly for 6 years. She was referred for investigation of renal impairment. The HbA1C is 9% urea 35 mg/dl, creatinine 2.0 mg/dl, Urine dipstick shows blood +, protein ++. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1197815",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197815,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>RA</strong> is a classic predisposing condition for <strong>AA amyloidosis</strong>.</li>\n<li>Chronic inflammation leads to increased serum amyloid A (SAA) protein, which deposits in the kidneys.</li>\n<li>Amyloidosis typically causes <strong>proteinuria</strong> (may be nephrotic range).</li>\n<li>Hematuria may also be seen.</li>\n<li>Given RFT suggests <strong>progressive renal impairment</strong>, often seen in <strong>amyloidosis</strong> or other glomerular pathologies.</li>\n</ul>\n<h3>Explanation of Other Options:</h3>\n<p><strong>Diabetic nephropathy(Option A): </strong>In Type II diabetes, the correlation between retinopathy and nephropathy is poor. Only 60% of patients with nephropathy have retinopathy coexisting. Nephropathy typically develops over the years</p>\n<p><strong>Chronic interstitial nephritis(Option C): </strong>Long NSAID use supports it, but CIN rarely causes ++ proteinuria. Chronic interstitial nephritis causes mild proteinuria. RBC is not seen in the urine.</p>\n<p><strong>Renal calculi(Option D):</strong> Would show <strong>gross/microscopic hematuria</strong>, <strong>pain</strong>, not heavy proteinuria or progressive renal impairment. Renal calculi are unlikely, as there is no history of pain or gross hematuria.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibromatosis type II</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Romano-Ward syndrome</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Alport's syndrome</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Adult polycystic kidney disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man had progressive deafness and hematuria from childhood and had undergone a renal transplant eight years ago for chronic renal failure. Examination revealed perceptual high-tone deafness and anterior lenticonus in both eyes. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1197819",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197819,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The combination of early-onset hematuria, high-frequency sensorineural deafness, and ocular abnormality (anterior lenticonus) strongly suggests <strong>Alport's syndrome</strong>, a hereditary nephritis.</p>\n<p><strong>Alport's Syndrome:</strong></p>\n<ul>\n<li>Genetics:<strong> X-linked inheritance</strong> of mutations in the &alpha;5(IV) collagen chain.</li>\n<li>Characterised by a triad of:</li>\n<li>Progressive <strong>hematuric nephritis</strong></li>\n<li>Progressive perceptive <strong>high-tone hearing loss</strong></li>\n<li><strong>Ocular signs </strong>(cataracts, spherophakia, and anterior lenticonus, dot and fleck retinopathy)</li>\n<li><strong>Renal Biopsy:</strong>\n<ul>\n<li><strong>Early features: </strong>thin basement membranes on renal biopsy, which thicken over time into multilamellations surrounding lucent areas that often contain granules of varying the so-called split basement membrane.</li>\n<li><strong>Advanced disease:</strong> Tubules drop out, glomeruli scar, and the kidney eventually succumbs to interstitial fibrosis.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917af432fb4-a2a2-4d04-819d-6fc3db431c87.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Neurofibromatosis type II (Option A) </strong>presents with bilateral vestibular schwannomas causing hearing loss, but no hematuria, no lenticonus. NF is associated with stenosis of renal vessels.</p>\n<p><strong>Romano-Ward syndrome (Option B)</strong> is a congenital long QT syndrome without deafness. Jervell and Lange-Nielsen syndrome is another form of long QT syndrome associated with deafness, but it is not relevant here.</p>\n<p><strong>Adult polycystic kidney disease (Option D)</strong> is associated with Intracranial aneurysms, hepatic cysts, mitral valve prolapse, abdominal wall hernias, and colonic diverticulae.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulomatosis with polyangiitis</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Lupus nephritis</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tuberculosis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old male has had a 5-year history of renal failure. On examination, he had maculopapular rashes, erythema nodosum, arthritis, hepatomegaly, and splenomegaly. Chest X-ray shows hilar adenopathy. A renal biopsy specimen revealed tubulointerstitial nephritis and non-caseating granulomatous lesions. What is the diagnosis?</span></p>",
      "unique_key": "DT1197824",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The question deals with multi-system involvement with non-caseating or naked granulomas, which is characteristic of <strong>Sarcoidosis.</strong></p>\n<p><strong>Sarcoidosis:</strong></p>\n<ul>\n<li>Sarcoidosis is a chronic, multi-system granulomatous disorder of unknown aetiology characterised by <strong>non-caseating granulomas. </strong></li>\n<li>The most commonly affected organ is the <strong>lung</strong>; other organs include the lymph nodes, skin, eyes, parotid glands, bones, joints, liver, and kidneys.</li>\n<li>Patients mostly present with respiratory symptoms or joint and skin manifestations.</li>\n<li><strong>Renal involvement and presentation</strong> with renal failure are relatively rare in sarcoidosis.</li>\n<li><strong>Renal sarcoidosis</strong> is reported to have three categories:\n<ul>\n<li>Renal changes due to <strong>abnormal calcium metabolism </strong>(the most common cause of renal impairment in Sarcoidosis),</li>\n<li>Interstitial nephritis or granulomatous nephritis or granulomatous nephritis and</li>\n<li>Glomerulonephritis(mostly membranous).</li>\n</ul>\n</li>\n<li><strong>Multisystem involvement:</strong>\n<ul>\n<li><strong>Skin:</strong> Maculopapular rash, <strong>erythema nodosum</strong></li>\n<li><strong>Joints:</strong> Arthritis</li>\n<li><strong>Liver &amp; spleen:</strong> Hepatomegaly and splenomegaly</li>\n<li><strong>Lungs/Chest X-ray:</strong> Bilateral hilar lymphadenopathy</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Granulomatosis with polyangiitis (Option A) </strong>also involves the lungs in the form of pulmonary infiltrates or nodules, along with upper respiratory involvement. Hilar adenopathy is not seen. Cutaneous nodules and arthritis can also be seen, but hepatosplenomegaly has not been described. But the biopsy reveals necrotising granulomas.</p>\n<p><strong>Lupus nephritis (Option B) </strong>may cause an overlap of nephrotic and nephritic syndrome and may have a maculopapular rash, esp. on the face (butterfly distribution).</p>\n<p><strong>Renal tuberculosis (Option C) </strong>can occur as a late complication of primary TB and thus has hilar adenopathy, but causes caseating granulomas.</p>\n<p><br /> <br /> </p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythaemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Nail pitting</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypermobility</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man has been referred for management of hypertension. On examination, he had palpable kidneys. This was confirmed by abdominal ultrasound, which showed multiple cysts. Which of the following is likely to be associated?</span></p>",
      "unique_key": "DT1197828",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>A young hypertensive with palpable kidneys and cysts on ultrasound points to the diagnosis of</li>\n<li>ADPKD is associated with relatively<strong> higher erythropoietin (EPO) production </strong>compared to other CKD causes, leading to <strong>polycythemia</strong> in some patients, though anemia may still occur in advanced stages.</li>\n<li><strong>ADPKD </strong>is a genetic disorder characterised by the progressive development of multiple fluid-filled cysts in both kidneys.</li>\n<li>It is one of the<strong> most common inherited kidney diseases.</strong></li>\n<li><strong>Diagnostic Criteria (Ultrasound-based - Ravine criteria):</strong> <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509174331d2cc-01ef-4bf7-bfd8-e76d239ec4ea.png\"></li>\n<li><strong>Associations of ADPKD:</strong>\n<ul>\n<li><strong>Cardiovascular:</strong>\n<ul>\n<li>Intracranial aneurysm(5 times more common than in the general population) can rupture to cause subarachnoid haemorrhage</li>\n<li>Diffuse arterial dolichoectasia of the anterior and posterior cerebral circulation &rarr; predisposed to arterial dissection and stroke</li>\n<li>Mitral valve prolapse</li>\n</ul>\n</li>\n<li><strong>Gastrointestinal:</strong>\n<ul>\n<li>Colonic diverticula</li>\n<li>Abdominal wall hernia</li>\n<li>Polycystic liver disease</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091744ba8fb3-d89d-4720-8e6f-f8c0551a3672.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Nail pitting (Option B): </strong>Seen in psoriasis, not related to kidney cysts.</p>\n<p><strong>Hypermobility (Option C): </strong>Associated with connective tissue disorders like Ehlers-Danlos or Marfan syndrome, not ADPKD.</p>\n<p><strong>Mitral stenosis (Option D): </strong>Mitral valve prolapse (not stenosis) is the valvular lesion associated with ADPKD.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Analgesic nephropathy</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycystic kidney disease</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Reflux nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female with chronic urinary tract infections presents for investigations. Ultrasound scan reveals scarring over the renal calyces. Which one of the following is most likely?</span></p>",
      "unique_key": "DT1197831",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>A history of recurrent urinary tract infections with renal scarring over the renal calyces is typical of<strong> Reflux Nephropathy</strong>.</li>\n<li>It is a type of chronic interstitial nephritis.</li>\n<li>It is due to <strong>Vesico Ureteral reflux (VUR</strong>), from the bladder to one or both of the ureters, due to an incompetent vesicoureteral valve.</li>\n<li>VUR causes renal scarring, tubular dysfunction, and secondary FSGS.</li>\n<li>Often associated with <strong>recurrent urinary tract infections.</strong></li>\n<li>VUR is often <strong>asymptomatic </strong>and is common in <strong>females </strong>and is diagnosed during pregnancy or other routine evaluation. Hypertension is common. Proteinuria may be moderate.</li>\n<li>Ultrasound shows <strong>focal scarring </strong>over areas of calyces with areas of <strong>compensatory hypertrophy</strong>.</li>\n<li>Confirmation is by<strong> DMSA scan</strong>,<strong> MRI, or CT.</strong></li>\n<li><strong>Reimplantation of ureters</strong> is indicated if renal scarring has not occurred and with high-grade reflux.</li>\n<li>Maintenance of sterile urine with <strong>prophylactic antibiotics</strong> and <strong>ACEI or ARBs </strong>for proteinuria may retard the progression.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917bc9dc1ca-c7f5-4427-b2ec-26d91e7612e3.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Analgesic nephropathy (Option A) </strong>is associated with chronic NSAID use. Causes papillary necrosis, not necessarily focal calyceal scarring. Typically seen in older patients, especially females with chronic pain disorders.</p>\n<p><strong>Polycystic kidney disease (Option B) </strong>causes bilateral kidney enlargement and multiple cysts, not focal calyceal scarring.</p>\n<p><strong>Nephrotic syndrome (Option C) </strong>is characterized by heavy proteinuria, oedema, and hypoalbuminemia.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Alfacalcidol</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium acetate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57-year-old man with diabetic nephropathy has a plasma creatinine of 4.3 mg/dl (NR 0.6-1.4 mg/dl), potassium 5.2 mmol/l, calcium 8.8 mg/dl, albumin 4.2 g/dl, phosphate 4.4 mg/dl, and PTH 1.6 pmol/l (NR 1.4-6.8). Which of the following should be commenced?</span></p>",
      "unique_key": "DT1197837",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The basic problem in CKD is <strong>phosphate retention</strong> due to decreased GFR and decreased Vitamin D activation due to <strong>1&alpha; hydroxylase deficiency</strong>, which leads to hypocalcemia, and both lead to increased PTH production and secondary hyperparathyroidism.</li>\n<li>Uncontrolled secondary hyperparathyroidism leads to osteitis fibrosa cystica.</li>\n<li>So, treatment of <strong>Secondary hyperparathyroidism</strong> is essential to prevent bone changes.</li>\n<li>The first step is to restrict dietary phosphorus</li>\n<li>The next step is <strong>phosphate binders</strong>.</li>\n<li><strong>Calcium acetate</strong> is preferred as a <strong>phosphate binder </strong>in this patient with elevated phosphate and secondary hyperparathyroidism, as it binds dietary phosphate effectively with a lower calcium load compared to <strong>calcium carbonate.</strong></li>\n<li><strong>Non calcium-containing phosphate binders</strong> are aluminium-containing antacids, ferric citrate, sucroferric oxohydroxide, and magnesium.</li>\n<li>Phosphate-binding resins include <strong>Sevelamer</strong> and</li>\n<li>Calcium levels should be measured and corrected.</li>\n<li>Vitamin D levels should be measured and corrected. Calcitriol and 1&alpha;-hydroxylated vitamin D are given to treat secondary hyperparathyroidism after correcting phosphate levels and monitoring of 25-hydroxy vitamin D levels.</li>\n<li>So this patient should be treated with <strong>dietary phosphate deficiency, calcium supplements,</strong> and a <strong>phosphate binder</strong>. Since Calcium carbonate can act as a phosphate binder and source of calcium, it can be given.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509174f1b6612-1f13-42d0-a5a6-6cee4d2b1ccc.png\">\n<p>Explanation of Other Options:</p>\n<p><strong>Thyroxine (Option A): </strong>No evidence of hypothyroidism is provided. Normal albumin and no signs/symptoms suggesting thyroid dysfunction.</p>\n<p><strong>Vitamin A (Option B): </strong>Excess Vitamin A is toxic in CKD and may worsen bone disease.</p>\n<p><strong>Alfacalcidol (Option C) </strong>could be considered for prophylaxis against renal bone disease and progressive hyperparathyroidism. However, the patient's phosphate level is already elevated, and vitamin D supplementation may increase this further.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic tubulointerstitial disease</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Obstructive Uropathy</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Analgesic nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old woman is referred for investigation of a creatinine of 2.5 mg/dl. She mentioned several episodes of haematuria with symptoms of ureteric colic. She has a long history of low back pain treated with a combination of painkillers. An ultrasound shows two irregularly shaped kidneys, size 8.5 and 9 cm, and renal papillary calcifications. Which of the following is the most likely?</span></p>",
      "unique_key": "DT1197845",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This elderly woman with long-term analgesic use, renal impairment, hematuria, and papillary calcifications has classic features of <strong>analgesic nephropathy</strong>, a form of chronic tubulointerstitial nephritis.</p>\n<p><strong>Analgesic Nephropathy: </strong></p>\n<ul>\n<li>Result of prolonged or chronic ingestion of combination analgesics that contain <strong>phenacetin or acetaminophen </strong>and <strong>nonsteroidal anti-inflammatory drugs (NSAIDs)</strong>, including aspirin and caffeine.</li>\n<li>Usual NSAIDs(ibuprofen, diclofenac) do not cause Analgesic nephropathy</li>\n</ul>\n<h3>Pathophysiology:</h3>\n<ul>\n<li><strong>Direct tubular toxicity</strong> from analgesic metabolites.</li>\n<li><strong>Papillary ischemia and necrosis</strong> due to inhibition of prostaglandin synthesis &rarr; reduced renal blood flow.</li>\n<li>Chronic use &rarr; repeated insults &rarr; <strong>chronic tubulointerstitial inflammation</strong> &rarr; fibrosis and <strong>renal papillary necrosis</strong>.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li><strong>Flank pain: </strong>From papillary necrosis or obstructive debris</li>\n<li><strong>Hematuria: </strong>Often microscopic, may be gross during necrosis</li>\n<li><strong>Polyuria, nocturia:</strong> Due to impaired concentrating ability (tubular damage)</li>\n<li><strong>Chronic renal insufficiency: </strong>Slowly progressive</li>\n<li><strong>Hypertension</strong></li>\n</ul>\n<p><strong>Investigations:</strong></p>\n<ul>\n<li><strong>Urine analysis:</strong> Hematuria, sterile pyuria, mild proteinuria</li>\n<li><strong>Serum creatinine/urea:</strong> Raised (chronic kidney disease)</li>\n<li><strong>Ultrasound: </strong>Small, <strong>shrunken kidneys</strong>, <strong>irregular contour</strong>, <strong>papillary calcifications</strong></li>\n<li><strong>CT KUB: </strong>Better for visualising <strong>papillary necrosis, calcifications</strong></li>\n<li><strong>Biopsy (rarely needed): </strong>Interstitial fibrosis, tubular atrophy, necrotic papillae</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Chronic tubulointerstitial disease (Option A): </strong>NSAID-induced tubulointerstitial disease will not present with colic and hematuria.</p>\n<p><strong>Chronic Obstructive Uropathy (Option B): </strong>Usually associated with hydronephrosis or post-void residual urine. No evidence of bladder outlet obstruction or prostate issues in this elderly woman.</p>\n<p><strong>Multiple myeloma (Option C): </strong>There is no other information given in the question that suggests a myeloma other than low back pain. Myeloma does not produce colic and hematuria. It will not cause shrunken kidneys. Myeloma causes CKD with normally sized kidneys.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalaemia</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron overload</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old man with CKD has been on EPO injections 3 times a week for several years. Which one of the following is a side effect of erythropoietin therapy?</span></p>",
      "unique_key": "DT1197850",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197850,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Erythropoietin (EPO) </strong>is commonly used in chronic kidney disease (CKD) to treat anaemia due to reduced endogenous erythropoietin production.</p>\n<p><strong>Known Side Effects:</strong></p>\n<ul>\n<li><strong>Hypertension </strong>(most common)</li>\n<li>Seizures (rare but recognised, especially with rapid rise in haemoglobin)</li>\n<li>Flu-like symptoms</li>\n<li>Thrombosis (including access clotting in dialysis patients)</li>\n<li>Pure red cell aplasia (rare, anti-EPO antibodies)</li>\n<li>Increased PCV</li>\n<li>Thrombocythemia</li>\n<li>Thrombosis</li>\n<li>Iron deficiency</li>\n<li>Urticaria.</li>\n</ul>\n<p><strong>Indications for Exogenous EPO Therapy:</strong></p>\n<ul>\n<li>Anaemia in Chronic Kidney Disease (CKD)</li>\n<li>Anaemia in cancer patients on chemotherapy</li>\n<li>HIV patients on zidovudine</li>\n<li>Pre-op use to minimise blood transfusions</li>\n<li>Anaemia of chronic disease (select cases)</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypokalaemia(Option A): </strong>EPO does not directly cause hypokalaemia; hyperkalaemia is more common in CKD.</p>\n<p><strong>Osteoporosis(Option B): </strong>EPO does not affect bone density; osteoporosis is unrelated.</p>\n<p><strong>Iron overload(Option D):</strong> EPO can cause iron deficiency, not overload, due to increased erythropoiesis.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Urea disequilibrium</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Small vessel ischaemia</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Aluminium toxicity</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man who has been on hemodialysis for 20 years has progressive dementia. Which one of the following is most likely to have caused this?</span></p>",
      "unique_key": "DT1197863",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197863,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient with progressive dementia after long-term hemodialysis likely has <strong>aluminium toxicity</strong>, especially if exposed to aluminium-containing phosphate binders or non-deionised water. Aluminium accumulation in the brain can cause <strong>dialysis dementia</strong>, a known complication of chronic dialysis in earlier eras.</p>\n<p><strong>Aluminium encephalopathy</strong> (dialysis dementia):</p>\n<ul>\n<li>Occurs in patients on long-term dialysis</li>\n<li>Associated with progressive dementia, speech disturbances, myoclonus, seizures, and behavioural changes</li>\n</ul>\n<p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>Aluminium crosses the <strong>blood-brain barrier</strong> and accumulates in the <strong>grey matter</strong>, especially the <strong>hippocampus and cortex</strong>.</li>\n<li>Leads to <strong>neuronal degeneration</strong>, demyelination, and spongiform changes.</li>\n<li>Associated with <strong>microglial activation</strong> and <strong>astrocyte dysfunction</strong>.</li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li><strong>Clinical suspicion</strong> in long-term dialysis patients with neurologic symptoms</li>\n<li><strong>History of aluminium exposure</strong></li>\n<li><strong>Serum aluminium levels</strong></li>\n<li><strong>MRI brain</strong>: nonspecific atrophy; sometimes cortical signal changes</li>\n<li><strong>Bone biopsy</strong>: evidence of aluminium accumulation</li>\n</ul>\n<p><strong>Treatment:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917cbfb08f7-1ba1-47b3-b968-18071ba12999.png\">\n<p><strong>Prevention:</strong></p>\n<ul>\n<li>Avoid aluminium-based phosphate binders</li>\n<li>Use <strong>aluminium-free dialysate</strong></li>\n<li>Routine monitoring of <strong>serum aluminium</strong> in dialysis patients</li>\n<li>Education on <strong>medication safety</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Urea disequilibrium (Option A) </strong>occurs immediately after dialysis, not years later; presents with acute cerebral oedema, nausea, and confusion</p>\n<p><strong>Small vessel ischaemia (Option B) </strong>can cause dementia, but not the most characteristic or expected in this dialysis context.</p>\n<p><strong>Amyloidosis (Option D) </strong>can occur with long-term dialysis (&gt;10 years), but it typically affects joints, bones, and heart, not predominantly dementia</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Gout</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium pyrophosphate deposition</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;2 microglobulin amyloidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man has been on haemodialysis for 15 years due to diabetic nephropathy. He now has joint pain in the shoulders and knees. He has a past medical history of bilateral carpal tunnel decompression. His blood reveals: Hb 11 g/dl, ESR 50 mm/hr, urea 108 mg/dl, creatinine 2.50 mg/dl, sodium 142 mmol/l, potassium 4.4 mmol/l, Urate 0.6 (< 0.45). What is the likely diagnosis?</span></p>",
      "unique_key": "DT1197866",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197866,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>All of the features mentioned strongly suggest <strong>Dialysis-Related Amyloidosis (DRA) </strong>due to<strong> &beta;2-microglobulin deposition.</strong></p>\n<p><strong>Key Features:</strong></p>\n<ul>\n<li>Amyloid deposits are composed of &beta;2 microglobulin</li>\n<li>Develop approximately <strong>&gt; 12 years</strong> of dialysis.</li>\n<li><strong>Carpal Tunnel syndrome</strong> is the first presentation.</li>\n<li><strong>Joints</strong> involved are bilateral and symmetrical, and large joints.</li>\n<li>Joint effusions are non-inflamed and contain &beta;2 microglobulin on <strong>Congo red.</strong></li>\n<li>There will be visceral deposits of <strong>&beta;2 microglobulin.</strong></li>\n<li>The incidence of &beta;2-microglobulin amyloidosis is now reduced due to improvements in dialysis membranes.</li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li>Clinical + confirmed via biopsy (Congo red staining, &beta;2-microglobulin immunostaining)</li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>High-flux dialysis, renal transplant (definitive), symptomatic relief for joint issues</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Gout (Option A) </strong>typically affects the first MTP joint, not large joints like shoulders; associated with elevated uric acid, which is not seen here; not linked to long-term dialysis.</p>\n<p><strong>Polymyalgia Rheumatica (Option B) </strong>causes muscle stiffness, especially in the shoulders and hips, with very high ESR (&gt;100 mm/hr); it does not cause carpal tunnel syndrome or occur due to dialysis.</p>\n<p><strong>Calcium Pyrophosphate Deposition (Option C) </strong>affects knees and wrists, may show chondrocalcinosis, but is not related to dialysis or carpal tunnel syndrome; &beta;2-microglobulin deposition is not a feature.</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Gliclazide</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year diabetic patient is on the following medication: Metformin 1g tds, Gliclazide 80 mg bd, Ramipril 5 mg daily, and Atenolol 50 mg. Her blood results show: urea 78 mg/dl, creatinine 2.15 mg/d, sodium 138 mmol/L, potassium 4.0 mmol/l. Which of the following medications should be withdrawn?</span></p>",
      "unique_key": "DT1197870",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Metformin</strong> is contraindicated or used with extreme caution when eGFR &lt; 30 ml/min/1.73 m&#178;</li>\n<li><strong>Risk: </strong>Lactic acidosis, a rare but potentially fatal complication</li>\n<li>Guidelines recommend:\n<ul>\n<li>Stop metformin if eGFR &lt; 30</li>\n<li>Reduce dose if eGFR is between 30-45, and reassess</li>\n</ul>\n</li>\n<li>The drugs that should be avoided in renal failure are <strong>Metformin, Meperidine, NSAIDs</strong>, and<strong> OHAs </strong>that are eliminated by the kidneys.</li>\n<li><strong>Sulfonyl ureas </strong>should be avoided only in advanced renal failure.</li>\n<li><strong>ACE inhibitors or ARBs </strong>should be stopped if there is a &gt;30% rise in serum creatinine within 2 weeks of initiation or dose increase, or if hyperkalemia develops.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Gliclazide (Option A)</strong>, a sulfonylurea, can be used in CKD with caution and dose adjustment due to increased hypoglycemia risk in reduced GFR. It is safer than other sulfonylureas like glibenclamide, which are contraindicated in advanced renal failure.</p>\n<p><strong>Atenolol (Option C)</strong> is a beta blocker. Dose adjustment may be needed in CKD, but not contraindicated</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischaemic nephropathy</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Analgesic nephropathy</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial nephritis</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal change nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old lady has investigations for renal impairment (creatinine 2.4 mg/dl). She has a previous history of hypertension, peripheral vascular disease, and osteoarthritis. She has been taking diclofenac for 6 years and penicillamine for the past 2 years (the drug was stopped 1 year ago). Investigations show: Urine: protein +, blood -ve. Ultrasound of kidneys: right 6 cm, left 8 cm in length. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1197878",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's history of hypertension and peripheral vascular disease, along with asymmetrically small kidneys on ultrasound (right 6 cm, left 8 cm), points toward chronic ischaemic damage due to <strong>renal artery stenosis.</strong> The mild proteinuria without hematuria further supports<strong> ischaemic nephropathy</strong>.</p>\n<p><strong>Ischaemic nephropathy: </strong></p>\n<ul>\n<li>Chronic kidney damage due to progressive narrowing or occlusion of the renal arteries, usually secondary to atherosclerosis.</li>\n<li>It results in reduced renal perfusion, ischemia, and loss of kidney mass/function.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091754c71f21-8504-4d0c-9ea2-0c8aaef4e86b.png\">\n<p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>&darr; Renal perfusion &rarr; activation of <strong>RAAS</strong> &rarr; <strong>hypertension</strong></li>\n<li>Chronic ischemia &rarr; interstitial fibrosis, tubular atrophy, and glomerulosclerosis</li>\n<li>Leads to <strong>small, shrunken kidneys</strong> (often <strong>asymmetrical</strong>)</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Hypertension</li>\n<li>Progressive renal failure</li>\n<li>Asymmetrical small kidneys</li>\n<li>Flash pulmonary oedema</li>\n<li>Abdominal bruit</li>\n</ul>\n<p><strong>Investigations:</strong></p>\n<ul>\n<li>Ultrasound KUB: Small kidney(s), asymmetry in size</li>\n<li>Doppler Renal USG</li>\n<li>CT/MR Angiography: Non-invasive confirmation of stenosis</li>\n<li>Renal angiography: Gold standard but invasive</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Analgesic nephropathy (Option B) </strong>is not possible as there is no history of combination pill intake or renal colic and hematuria.</p>\n<p><strong>Interstitial nephritis (Option C) </strong>will cause minimal proteinuria, but ultrasound will show symmetric kidneys.</p>\n<p><strong>Minimal change nephropathy (Option D):</strong> Minimal change disease presents with nephrotic range proteinuria.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Aluminum phosphate binders</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Alfacalcidol supplements</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the length of haemodialysis</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin supplements</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man has end-stage renal failure due to diabetes. He receives 4 hours of haemodialysis, 3x weekly. His pressure is 180/105 mmHg pre-dialysis and 160/90 mmHg post-dialysis. Pre-dialysis bloods show: Hb 10 g/dL, sodium 132 mmol/l, potassium 6.5 mmol/L, phosphate 1mmol/L, urea 270 mg/dl, creatinine 12.7 mg/dl, calcium 8.6 mg/dl. What is the best management step?</span></p>",
      "unique_key": "DT1197881",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient has hyperkalemia (K 6.5 mmol/L), high urea (270 mg/dL), and hypertension, indicating <strong>inadequate dialysis</strong>. <strong>Increasing dialysis</strong> duration improves the clearance of potassium, urea, and fluid, addressing these issues.</p>\n<p><strong>Increasing dialysis duration</strong> will:</p>\n<ul>\n<li>Improve <strong>potassium clearance</strong></li>\n<li>Lower <strong>urea</strong></li>\n<li>Help <strong>volume control &rarr; lower BP</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Aluminium phosphate binders (Option A) </strong>are not indicated as the patient's phosphate level is elevated, and aluminum binders are rarely used due to toxicity risks.</p>\n<p><strong>Alfacalcidol supplements (Option B): </strong>Vitamin D supplementation may be beneficial for secondary hyperparathyroidism, but it is not the priority here, as increasing dialysis duration addresses hyperkalemia, uremia, and hypertension more effectively.</p>\n<p><strong>Erythropoietin supplements (Option D): </strong>EPO supplements are probably beneficial; longer dialysis sessions would help clear the fluid overload and reno-toxins.</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-GBM disease</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">SLE with Lupus nephritis</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulomatosis with polyangiitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presents with seizures, hypertension, and photosensitivity. Bloods show: Hb 11 g/dl, WBC 8000/&mu;L, platelets 180000/&mu;L, urea 98 mg/dl, creatinine 3.2 mg/dl, sodium 140 mmol/l, potassium 5 mmol/l, ESR 100 mm/hr, CRP 25 mg/l. Urine showing 3+ protein and hematuria. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1197885",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197885,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>A young female with a history of seizures, hypertension, and photosensitivity rash, who has renal impairment with hematuria and proteinuria, high ESR points to the diagnosis of <strong>SLE with Lupus nephritis</strong>.</p>\n<p><strong>Lupus Nephritis:</strong></p>\n<ul>\n<li>Serious complication of <strong>Systemic Lupus Erythematosus (SLE)</strong> that involves inflammation of the kidneys due to immune complex deposition.</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Immune complex deposition (mainly anti-dsDNA antibodies) in the glomeruli.</li>\n<li>Leads to complement activation &rarr; glomerular inflammation and damage.</li>\n<li>Commonly associated with <strong>low complement levels (C3, C4)</strong> and <strong>positive ANA, anti-dsDNA</strong>.</li>\n</ul>\n</li>\n<li><strong>Classification:</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917997bde39-d693-427e-ae2e-7d40b20847a3.png\"></li>\n<li><strong>Investigations:</strong>\n<ul>\n<li><strong>Urinalysis</strong>: proteinuria, hematuria, RBC casts</li>\n<li><strong>Serum creatinine</strong>: elevated in advanced stages</li>\n<li><strong>Serology</strong>:\n<ul>\n<li>ANA: positive</li>\n<li>Anti-dsDNA: high</li>\n<li>Low complement (C3, C4)</li>\n</ul>\n</li>\n<li><strong>Renal biopsy</strong>: gold standard for diagnosis and classification<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091749229af3-54a9-439c-932c-d76258c17e7e.png\"></li>\n</ul>\n</li>\n</ul>\n<p>Explanation of Other Options:</p>\n<p><strong>Anti-GBM disease (Option A)</strong> is a cause of rapidly progressive glomerulonephritis, which presents as an acute nephritic syndrome leading to renal failure and may also affect the lungs, causing diffuse alveolar haemorrhage, which presents with hypoxemia and haemoptysis.</p>\n<p><strong>Multiple myeloma (Option B)</strong> causes renal impairment, but the patient profile will be an elderly patient with skeletal pains, hypercalcemia, and renal impairment. There will be anaemia, high ESR, albumin-globulin ratio reversal, and hypercalcemia. Skeletal survey shows a lytic lesion.</p>\n<p><strong>Granulomatosis with polyangiitis (Option D)</strong> is a small vessel vasculitis which causes rapidly progressive glomerulonephritis (RPGN) along with pulmonary cavities &amp; infiltrates and is characterised by cANCA positivity.</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyaline thrombus formation</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesangial hypercellularity</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Basement membrane spikes</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Basement membrane thickening and mesangial widening</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old diabetic gentleman had a renal biopsy during investigation of worsening renal failure. Which of the following is typical of diabetic nephropathy?</span></p>",
      "unique_key": "DT1197893",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197893,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The earliest morphologic abnormality in <strong>diabetic nephropathy</strong> is the <strong>thickening of the glomerular basement membrane (GBM) </strong>and <strong>expansion of the mesangium due to accumulation of extracellular matrix</strong>.</p>\n<p><strong>Diabetic Nephropathy:</strong></p>\n<ul>\n<li>A chronic microvascular complication of <strong>diabetes mellitus</strong> affecting the glomeruli, leading to progressive <strong>albuminuria</strong>, <strong>hypertension</strong>, and <strong>renal failure</strong>.</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li><strong>Chronic hyperglycemia</strong> &rarr; non-enzymatic glycation of proteins &rarr; basement membrane damage</li>\n<li>Activation of <strong>RAAS</strong>, oxidative stress, and cytokines (TGF-&beta;) &rarr; <strong>mesangial expansion</strong>, GBM thickening</li>\n<li>Progressive glomerulosclerosis (esp. <strong>Kimmelstiel-Wilson nodules</strong>)</li>\n</ul>\n</li>\n<li><strong>Stages (Mogensen Classification):</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509175d105f50-c9ed-4b2c-9e46-2c4e9c22e5a6.png\"></li>\n<li><strong>Histopathology:</strong>\n<ul>\n<li>Light microscopy findings show an increase in the solid spaces of the tuft material (diffuse diabetic glomerulopathy).</li>\n<li><strong>Kimmelstiel-Wilson nodules, </strong>which are PAS-positive, contain eosinophilic material.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231220ca183a64-ba9b-4089-b244-60076e6c2864.png\"></li>\n</ul>\n</li>\n<li><strong>Diagnosis:</strong>\n<ul>\n<li><strong>Urine ACR (Albumin-Creatinine Ratio)</strong>:\n<ul>\n<li>Microalbuminuria: 30-300 mg/g</li>\n<li>Macroalbuminuria: &gt;300 mg/g</li>\n</ul>\n</li>\n<li><strong>Serum creatinine, eGFR</strong></li>\n<li><strong>Fundus exam</strong>: Retinopathy supports DN diagnosis</li>\n<li><strong>Renal biopsy</strong>: Not routinely done unless atypical features (hematuria, rapid progression)</li>\n</ul>\n</li>\n</ul>\n<p>Explanation of Other Options:</p>\n<p><strong>Hyaline thrombus formation (Option A):</strong> Hyaline changes in blood vessels are seen in hypertension and are nonspecific.</p>\n<p><strong>Mesangial hypercellularity (Option B)</strong> is seen in glomerular diseases like Ig A nephropathy, Lupus Nephritis, post-streptococcal glomerulonephritis, etc.</p>\n<p><strong>Basement membrane spikes(Option C)</strong> are characteristic of membranous nephropathy, which presents with nephrotic syndrome, not the nephritic features seen in diabetic nephropathy.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased dialysis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A haemodialysis patient has recurrent knee and ankle swelling and pain. Aspiration of the knee synovial fluid reveals negatively birefringent crystals. Which one of the following treatments is the least effective either acutely or in a chronic situation?</span></p>",
      "unique_key": "DT1197898",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197898,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Negatively birefringent, needle-shaped crystals under polarized light confirm urate crystals, diagnostic of<strong> gout. Probenecid </strong>is ineffective in dialysis patients as it requires renal function to promote uric acid excretion, making it the least effective treatment.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231117fbfeb65d-7e2f-4a52-8aa2-6bd476d83208.png\">\n<p><strong>Acute attack management in CKD:</strong></p>\n<ul>\n<li><strong>NSAIDS </strong>should <strong>not </strong>be used in<strong> CKD</strong>.</li>\n<li>Colchicine requires dose reduction in CKD.</li>\n<li><strong>Steroids</strong> are safe in CKD: First-line in moderate-severe CKD <strong>(Option B)</strong></li>\n</ul>\n<p><strong>Urate-lowering agents:</strong></p>\n<ul>\n<li><strong>Allopurinol </strong>is a xanthine oxidase inhibitor and can be used in CKD with dose reduction.</li>\n<li><strong>Febuxostat </strong>is another xanthine oxidase inhibitor and requires no dose reduction in moderate to severe renal impairment. <strong>(Option D)</strong></li>\n</ul>\n<p><strong>Uricosuric drugs:</strong></p>\n<ul>\n<li><strong>Probenecid </strong>is<strong> not </strong>effective in<strong> renal impairment</strong>, Cr &gt;2mg/dl.&nbsp;</li>\n<li>Benzbromarone is useful in renal impairment.</li>\n<li>Haemodialysis will also ease urate clearance. <strong>(Option C)</strong></li>\n</ul>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Adynamic bone disease</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Dialysis amyloid</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroid bone disease</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D-induced hypercalcaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man, who has been on haemodialysis for 12 years, presents with gradually increasing bone pain. He underwent a subtotal parathyroidectomy 4 years ago. Current medications include alfacalcidol 1 mg/day and calcium carbonate 500 mg three times daily. His serum calcium concentration is 10.6 mg/dl, and phosphate is 2.8 mg/dl. What is the most probable cause of his symptoms?</span></p>",
      "unique_key": "DT1197920",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197920,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Despite previous subtotal parathyroidectomy, ongoing bone pain in a dialysis patient with high-normal calcium suggests <strong>persistent or recurrent hyperparathyroid bone disease (osteitis fibrosa cystica)</strong>. This condition is common in long-term dialysis due to <strong>secondary or tertiary hyperparathyroidism.</strong></p>\n<p><strong>Renal Osteodystrophy (CKD-MBD)</strong></p>\n<p>Renal osteodystrophy refers to bone pathology resulting from CKD-related disturbances in calcium, phosphate, PTH, and vitamin D metabolism.</p>\n<p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>&darr; GFR &rarr; &darr; phosphate excretion &rarr; hyperphosphatemia</li>\n<li>Hyperphosphatemia + &darr; renal 1&alpha;-hydroxylase &rarr; &darr; active Vitamin D (calcitriol) &rarr; &darr; calcium absorption</li>\n<li>Leads to hypocalcemia &rarr; triggers secondary hyperparathyroidism</li>\n<li>Chronic PTH elevation &rarr; bone resorption</li>\n<li>Also contributes: metabolic acidosis &rarr; bone buffering &rarr; loss of minerals</li>\n</ul>\n<p><strong>Types of Bone Disease in CKD-MBD:</strong></p>\n<ul>\n<li><strong>Osteitis Fibrosa Cystica (High-turnover)</strong>\n<ul>\n<li>Caused by secondary hyperparathyroidism</li>\n<li>&uarr; PTH &rarr; bone resorption, marrow fibrosis</li>\n<li>Classic form of renal osteodystrophy</li>\n</ul>\n</li>\n<li><strong>Adynamic Bone Disease (Low-turnover)</strong>\n<ul>\n<li>Due to over-suppression of PTH (e.g., excessive vitamin D or calcium)</li>\n<li>Minimal bone formation/resorption</li>\n<li>Common in the elderly, diabetics, and post-parathyroidectomy</li>\n</ul>\n</li>\n<li><strong>Osteomalacia</strong>\n<ul>\n<li>Defective bone mineralization due to vitamin D deficiency or aluminium toxicity</li>\n<li>Bone is unmineralized &rarr; soft bones, fractures</li>\n<li>Mixed Uremic Osteodystrophy: Combination of high and low turnover lesions</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Bone pain</li>\n<li>Fractures (especially vertebral, long bones)</li>\n<li>Skeletal deformities</li>\n<li>Growth retardation in children</li>\n</ul>\n</li>\n<li><strong>Diagnosis:</strong>\n<ul>\n<li>&uarr; or &darr; PTH levels (depending on type)</li>\n<li>&uarr; serum phosphate, &darr; or normal calcium</li>\n<li>&uarr; alkaline phosphatase (esp. in high-turnover disease)</li>\n<li>Bone biopsy (gold standard, rarely done)</li>\n<li>Imaging: X-rays may show subperiosteal resorption (in osteitis fibrosa), Looser zones (in osteomalacia)</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li>Phosphate binders (e.g., sevelamer, calcium acetate)</li>\n<li>Vitamin D analogs (e.g., calcitriol, alfacalcidol)</li>\n<li>Calcimimetics (e.g., cinacalcet - lowers PTH)</li>\n<li>Parathyroidectomy in refractory hyperparathyroidism</li>\n<li>Dialysis adequacy</li>\n<li>Avoid aluminium-based antacids (risk of osteomalacia)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Adynamic Bone Disease(Option A):</strong> Seen in long-term dialysis patients. Often due to <strong>oversuppression of PTH</strong> by excessive vitamin D and calcium therapy. Usually associated with <strong>low PTH, normal/high calcium,</strong> and <strong>low phosphate,</strong> which may seem similar here, <strong>but PTH level isn&rsquo;t provided</strong>, and he had a <strong>history of subtotal parathyroidectomy,</strong> so persistent PTH production is possible.</p>\n<p><strong>Dialysis Amyloid (Option B):</strong> Typically causes <strong>joint-related symptoms,</strong> not isolated bone pain. <strong>Bone pain in dialysis amyloidosis is more localized</strong> and often associated with <strong>pathological fractures</strong> or <strong>carpal tunnel signs.</strong></p>\n<p><strong>Vitamin D-induced Hypercalcemia(Option D): Calcium is mildly elevated,</strong> not high enough to cause bone pain alone. Hypercalcemia from vitamin D usually causes <strong>systemic symptoms</strong> like <strong>confusion, nausea, vomiting, polyuria, dehydration,</strong> and not isolated <strong>bone pain.</strong> Vitamin D-induced bone disease would more likely lead to <strong>adynamic bone disease</strong> due to PTH suppression, but again, the symptoms don't match.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Adynamic bone disease</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Aluminium deposition at the osteoid bone interface</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">An increase in plasma cells</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteitis fibrosa cystica</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with long-standing type 2 diabetes, who has recently started on peritoneal dialysis, is admitted with a fractured femoral neck. His serum calcium concentration is 11.6 mg/dl, phosphate is 6 mg/dL, and PTH is 5.6 pg/mL (normal range 10-65). Medications include alfacalcidol 0.5 mg daily and calcium carbonate 500 mg three times daily. What would a bone biopsy show?</span></p>",
      "unique_key": "DT1197923",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The low PTH in the presence of hypercalcemia and hyperphosphatemia indicates oversuppression of parathyroid activity, likely due to excessive calcium and vitamin D (alfacalcidol) intake, leading to <strong>adynamic bone disease </strong>characterized by low bone turnover and increased fracture risk.</p>\n<p><strong>Adynamic Bone Disease:</strong></p>\n<ul>\n<li>A form of renal osteodystrophy characterised by low bone turnover due to suppressed parathyroid hormone (PTH) activity.</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li><strong>Suppressed PTH levels</strong> &rarr; &darr; osteoblast and osteoclast activity</li>\n<li>Leads to <strong>low bone formation</strong>, <strong>reduced remodelling</strong>, and <strong>bone fragility</strong></li>\n<li>Bone becomes structurally weak, even though mineralisation may be normal</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Diffuse bone pain</li>\n<li>Fractures (especially non-traumatic)</li>\n<li>Muscle weakness</li>\n<li>Increased vascular calcification (due to excess calcium and phosphate)</li>\n<li>Often asymptomatic early</li>\n</ul>\n</li>\n<li><strong>Lab Findings:</strong>\n<ul>\n<li>PTH: Low or low-normal</li>\n<li>Calcium: Normal or mildly elevated</li>\n<li>Phosphate: Low or normal</li>\n<li>Alkaline phosphatase: Normal or low</li>\n<li>Bone biopsy: Low or absent osteoblasts/osteoclasts; low bone turnover</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Aluminium deposition at the osteoid bone interface (Option B):</strong> Aluminium deposited can cause osteomalacia-like picture and is seen with the use of aluminium as a phosphate binder and aluminium in dialysate.</p>\n<p><strong>An increase in plasma cells (Option C):</strong> An increase in plasma cells causes hypercalcemia and hypophosphatemia</p>\n<p><strong>Osteitis fibrosa cystica (Option D): </strong>Osteitis fibrosa cystica is severe secondary hyperparathyroidism.</p>",
      "correct_choice_id": 191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Candida albicans</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Escherichia coli</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcus epidermidis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man who is undergoing peritoneal dialysis at home presents with abdominal pain, pyrexia, and rigors. Examination is positive for peritoneal signs. Which organism is the most likely cause of this clinical picture?</span></p>",
      "unique_key": "DT1197928",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's symptoms suggest peritonitis, a common complication of <strong>peritoneal dialysis</strong>. The most frequent causative organisms are skin flora, especially <strong>Staphylococcus epidermidis</strong>, introduced during dialysis exchanges.</p>\n<p><strong>Peritoneal Dialysis-Associated Peritonitis:</strong></p>\n<ul>\n<li><strong>Most common cause:</strong> Staphylococcus epidermidis (~40-50%)</li>\n<li><strong>Other causes:</strong>\n<ul>\n<li>coli and other Gram-negative bacilli (~25%)</li>\n<li>Staphylococcus aureus (~15%)</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Abdominal pain (variable severity)</li>\n<li>Nausea, vomiting</li>\n<li>Cloudy peritoneal dialysis fluid</li>\n<li>Peritoneal signs: guarding, rebound tenderness</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal haemorrhage</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Occult malignancy</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiovascular disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the commonest cause of death in renal dialysis patients?</span></p>",
      "unique_key": "DT1197934",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197934,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Cardiovascular disease</strong> is the <strong>most common cause of death</strong> in dialysis patients.</p>\n<ul>\n<li>It includes:\n<ul>\n<li>Sudden cardiac death</li>\n<li>Ischemic heart disease</li>\n<li>Heart failure (often from left ventricular hypertrophy)</li>\n<li>Arrhythmias</li>\n<li>Vascular calcification</li>\n</ul>\n</li>\n</ul>\n<p><strong>Other leading causes of death in renal dialysis patients:</strong></p>\n<ul>\n<li><strong>Infections: The 2nd most common cause of death</strong>\n<ul>\n<li>Vascular access infections (e.g., catheter-related)</li>\n<li>Peritonitis (in peritoneal dialysis)</li>\n<li>Pneumonia, sepsis</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>\n<ul>\n<li>Uremia and chronic inflammation increase cancer risk</li>\n<li>Renal cell carcinoma (especially in acquired cystic kidney disease)</li>\n<li>Lymphomas, GI cancers</li>\n</ul>\n</li>\n<li><strong>Withdrawal from dialysis: </strong>Voluntary cessation in terminal or elderly patients due to poor quality of life or complications</li>\n<li><strong>Electrolyte disturbances: Hyperkalemia</strong> causing fatal arrhythmias, <strong>Calcium-phosphate imbalance</strong> causing vascular calcification</li>\n<li><strong>Hemorrhage: </strong>Due to uremic platelet dysfunction or anticoagulation during dialysis</li>\n</ul>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous urography</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Computed tomography(CT) scan</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Genetic screening</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal ultrasound scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man attends the transplant clinic with his brother, who has end-stage renal failure due to autosomal dominant polycystic kidney disease (ADPKD). He would like to donate a kidney to his brother if possible. Which of the following is the most appropriate modality for screening?</span></p>",
      "unique_key": "DT1197938",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197938,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In young potential donors (&lt;30 years) with a family history of ADPKD, particularly Type 2 (PKD2), ultrasound may miss small cysts due to lower sensitivity and the late onset of cyst formation. <strong>Genetic screening </strong>for PKD1 and PKD2 mutations provides definitive exclusion of ADPKD, ensuring the donor does not carry the disease.</p>\n<p>There may be cysts that are below the detection threshold of ultrasound. So, before donating kidney to a family member with ADPKD, genetic testing has to be done</p>\n<p><strong>Investigations in ADPKD:</strong></p>\n<p><strong>Ultrasound (USG Abdomen):</strong></p>\n<ul>\n<li>First-line and most commonly used.</li>\n<li>Shows multiple bilateral renal cysts.</li>\n<li>Diagnostic criteria depend on age and the number of cysts.</li>\n<li>Although ultrasound has a high degree of sensitivity for ADPKD type 1, the sensitivity for ADPKD type 2 is much lower because of the late age of onset, and a subject may be cleared to donate a kidney, yet still have the disease. <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>CT/MRI Abdomen:</strong></p>\n<ul>\n<li>More sensitive than USG.</li>\n<li>Detects smaller cysts, hemorrhage, infection, and extrarenal involvement (e.g., liver cysts).</li>\n<li>MRI is best for monitoring total kidney volume (TKV) progression.</li>\n<li>However, a CT scan exposes the patient to radiation and radiocontrast, which may cause serious allergic reactions and nephrotoxicity in patients with renal insufficiency. <strong>(Option B ruled out)</strong></li>\n</ul>\n<p><strong>Genetic Testing:</strong></p>\n<ul>\n<li>Detects mutations in PKD1 or PKD2 genes.</li>\n<li>Useful for Early diagnosis (especially in potential transplant donors), Equivocal imaging findings, and Family screening.</li>\n</ul>\n<p><strong>Intravenous urography: </strong>Intravenous urography has a poor sensitivity compared to all the investigations mentioned above, so not preferred <strong>(Option A ruled out)</strong></p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin deficiency</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C deficiency</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced red cell survival</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with chronic renal failure presents with anaemia. What is the most likely cause?</span></p>",
      "unique_key": "DT1197944",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197944,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Erythropoietin deficiency </strong>is the primary cause of anemia in CKD due to the loss of peritubular cells in the kidneys, which are responsible for EPO production.</p>\n<p><strong>Other Contributing Causes of Anaemia in CKD:</strong></p>\n<ul>\n<li><strong>Reduced red blood cell survival: </strong>Due to uremic toxins and chronic inflammation.</li>\n<li><strong>Iron deficiency: </strong>Caused by poor gastrointestinal absorption, blood loss (especially from dialysis), or frequent blood testing.</li>\n<li><strong>Bleeding tendency: </strong>Due to platelet dysfunction in uremia.</li>\n<li><strong>Hyperparathyroidism-induced bone marrow fibrosis </strong>reduces marrow erythropoiesis.</li>\n<li><strong>Nutritional deficiencies: Folate or vitamin B12 deficiency</strong> may contribute.</li>\n<li><strong>Chronic inflammation </strong>leads to functional iron deficiency and impaired erythropoiesis.</li>\n<li><strong>Comorbidities: </strong>Include hypo-/hyperthyroidism, pregnancy, HIV, autoimmune disease, and use of immunosuppressants.</li>\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptospirosis</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemolytic Uraemic Syndrome</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin treatment</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most likely to cause CKD?</span></p>",
      "unique_key": "DT1197951",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>IgA nephropathy</strong> is the most common primary glomerulonephritis worldwide and progresses to CKD in 20-40% of cases over 20 years, particularly in those with heavy proteinuria, hypertension, or renal impairment at presentation.</p>\n<p><strong>IgA Nephropathy:</strong></p>\n<ul>\n<li>A primary glomerulonephritis characterised by IgA immune complex deposition in the mesangium of the glomeruli.</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Abnormal glycosylation of <strong>IgA1</strong> &rarr; formation of autoantibodies against galactose-deficient IgA1</li>\n<li>Formation of circulating immune complexes</li>\n<li><strong>Deposition in mesangium</strong> &rarr; mesangial proliferation and inflammation</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Recurrent hematuria</li>\n<li>Mild proteinuria</li>\n<li>Hypertension</li>\n<li>Progressive renal dysfunction: in 20% to 40% over 20 years</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Diminished activity of renal 1&alpha; Hydroxylase</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemia</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased intestinal absorption of calcium</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoalbuminemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old man has been receiving dialysis for 6 years. His PTH is elevated at 345 pg/ml (Normal Range 25-65), phosphate 6.6 mg/dl, and corrected calcium 8 mg/dl. Of the following, which is the most likely to be responsible for renal osteodystrophy?</span></p>",
      "unique_key": "DT1197954",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197954,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The most likely cause of renal osteodystrophy in this dialysis patient is <strong>diminished activity of renal 1&alpha;-hydroxylase</strong>, which leads to decreased production of active vitamin D (calcitriol), causing hypocalcemia and secondary hyperparathyroidism.</p>\n<p><strong>Renal Osteodystrophy:</strong></p>\n<ul>\n<li>Refers to skeletal complications of chronic kidney disease (CKD) due to disordered bone and mineral metabolism</li>\n</ul>\n<p><strong>In CKD:</strong></p>\n<ul>\n<li>&darr; <strong>1&alpha;-hydroxylase activity</strong> &rarr; &darr; <strong>calcitriol</strong> &rarr; &darr; calcium absorption from gut</li>\n<li>&uarr; <strong>phosphate retention</strong> (due to &darr; excretion)</li>\n<li>&rarr; <strong>Hypocalcemia</strong> and <strong>hyperphosphatemia</strong></li>\n<li>&rarr; Stimulates <strong>parathyroid hormone (PTH)</strong> &rarr; <strong>Secondary hyperparathyroidism</strong></li>\n<li>Over time, bone changes due to <strong>PTH, FGF-23, vitamin D imbalance</strong>, etc.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917b390bb10-91dd-49a6-922a-9da9d9efd7c8.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypophosphatemia (Option B):</strong> Hyperphosphatemia contributes to bone disease, not low phosphate.</p>\n<p><strong>Increased intestinal absorption of calcium (Option C) </strong>would raise serum calcium, but here, calcium is low (8 mg/dL), and PTH is elevated, which is not consistent with increased calcium absorption.</p>\n<p><strong>Hypoalbuminemia (Option D):</strong> While it may lower total calcium, it doesn't directly cause secondary hyperparathyroidism or renal osteodystrophy.</p>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes Mellitus</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomerulonephritis</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic kidney disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a leading cause of chronic kidney disease?</span></p>",
      "unique_key": "DT1197955",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197955,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Diabetes mellitus</strong> is the leading cause of CKD in North America and Europe, while <strong>glomerulonephritis</strong>, particularly IgA nephropathy, is a leading cause in some developing regions.</p>\n<p><strong>Major Causes of CKD Globally:</strong></p>\n<ul>\n<li><strong>Diabetic nephropathy</strong> (most common worldwide, especially in type 2 diabetes)</li>\n<li><strong>Glomerulonephritis</strong> (e.g., IgA nephropathy - more common in some developing regions)</li>\n<li><strong>Hypertensive nephrosclerosis</strong></li>\n<li><strong>Polycystic kidney disease</strong> (particularly ADPKD)</li>\n<li><strong>Tubulointerstitial and cystic disorders</strong></li>\n</ul>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">CKD-EPI</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">MDRD</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Cockcroft Gault</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Kidney Failure Risk (KFR) equation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the best equation to determine eGFR?</span></p>",
      "unique_key": "DT1197956",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197956,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The <strong>CKD-EPI equation</strong> is preferred because it provides more accurate GFR estimates across a wider range of kidney function and populations, including those with near-normal GFR.</p>\n<p><strong>Methods for Estimating Renal Function:</strong></p>\n<ol>\n<li><strong>Serum Creatinine (S. Cr):</strong>\n<ul>\n<li>Commonly used in outpatient settings.</li>\n<li>Provides a <strong>rough estimate of GFR</strong>, but is influenced by muscle mass, age, and sex.</li>\n</ul>\n</li>\n<li><strong>Creatinine Clearance (CrCl):</strong>\n<ul>\n<li>Formula: <strong>(Urine Volume &times; Urine Creatinine) / (Plasma Creatinine &times; Time)</strong>.</li>\n<li>Requires 24-hour urine collection.</li>\n</ul>\n</li>\n<li><strong>Cockcroft-Gault Equation: (Option C)</strong>\n<ul>\n<li>Estimates <strong>creatinine clearance</strong> (CrCl), not GFR directly. <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2023122081cf4618-27f6-4e47-9bd5-d2e0b74aaee4.png\"></li>\n</ul>\n</li>\n<li><strong> MDRD Formula (Modification of Diet in Renal Disease): (Option B)</strong>\n<ul>\n<li>Calculates <strong>eGFR</strong> based on <strong>serum creatinine, age, sex, and race</strong>.</li>\n<li>Commonly used in lab reports but <strong>less accurate at higher GFRs (&gt;60 mL/min)</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202312205cc4225a-79d7-43a0-a4ba-427a7127bba9.png\"></li>\n</ul>\n</li>\n<li><strong> CKD-EPI Equation (Chronic Kidney Disease Epidemiology Collaboration):</strong>\n<ul>\n<li>Also estimates <strong>eGFR</strong>.</li>\n<li>More <strong>accurate than MDRD</strong>, especially when GFR is near-normal or mildly reduced.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\" https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231220ee1ef144-b61a-45d3-bbcd-9a3fc2769294.png\"></li>\n</ul>\n</li>\n</ol>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Kidney Failure Risk (KFR) equation (Option D):</strong> A Kidney Failure Risk (KFR) equation predicts the risk of progression to ESRD, not eGFR, unlike CKD-EPI, MDRD, and Cockcroft-Gault, which directly estimate renal function.</p>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotension</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac failure</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle cramps</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common acute complication of hemodialysis?</span></p>",
      "unique_key": "DT1219943",
      "question_audio": null,
      "question_video": null,
      "map_id": 1219943,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Hypotension</strong> is the most common acute complication of hemodialysis due to rapid fluid removal.</p>\n<p><strong>Hemodialysis:</strong></p>\n<p>A form of renal replacement therapy that removes toxins, excess fluid, and electrolytes via diffusion and ultrafiltration across a semipermeable membrane in a dialysis machine.</p>\n<p><strong>Acute Complications of Hemodialysis</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509173e3064f7-d0a6-494d-a772-5784df319cc2.png\">\n<p>Long-term (Chronic) Complications of Hemodialysis</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917a99ec4bd-43f3-45f7-8de0-dc13e44de455.png\">",
      "correct_choice_id": 281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">CKD poses a risk for bleeding as well as thrombosis.</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremic peripheral neuropathy occurs in stage 4 CKD</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose metabolism is impaired in CKD.</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Uremic pruritus improves dramatically with dialysis.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is false regarding CKD?</span></p>",
      "unique_key": "DT1219946",
      "question_audio": null,
      "question_video": null,
      "map_id": 1219946,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Uremic pruritus</strong> often <strong>persists despite adequate dialysis</strong> and does not improve dramatically, unlike many other skin symptoms in CKD.</p>\n<p><strong>Dermatological Manifestations in Chronic Kidney Disease:</strong></p>\n<p>Chronic kidney disease affects the skin in multiple ways, due to uremia, electrolyte imbalances, and dialysis-related complications</p>\n<ul>\n<li><strong>Pruritus (Uremic Pruritus): </strong>The most common skin symptom in CKD; generalized, worse at night, due to uremic toxins, hyperparathyroidism, dry skin, and calcium-phosphate imbalance.</li>\n<li><strong>Xerosis (Dry Skin): </strong>Dry, scaly skin from reduced sweat/sebaceous activity; commonly affects trunk and extensor surfaces, worsens itching.</li>\n<li><strong>Hyperpigmentation: </strong>Seen in sun-exposed areas due to elevated MSH and urochrome deposition.</li>\n<li><strong>Pallor:</strong> Results from anemia and vasoconstriction in CKD, causing pale skin and mucosa.</li>\n<li><strong>Calciphylaxis: </strong>Painful skin nodules that ulcerate and necrose; occurs in ESRD with high calcium/phosphate, diabetes, and warfarin use.</li>\n<li><strong>Nephrogenic Systemic Fibrosis (NSF):</strong> Scleroderma-like thickening and hardening of the skin after gadolinium exposure in advanced CKD (GFR &lt;30).</li>\n<li><strong>Nail Changes:</strong>\n<ul>\n<li>Half-and-half nails: Proximal white, distal brown band</li>\n<li>Muehrcke's lines: Paired white lines from hypoalbuminemia</li>\n<li>Terry's nails: White nail beds with pink distal band</li>\n</ul>\n</li>\n<li><strong>Hair and Mucosa:</strong>\n<ul>\n<li>Hair becomes dry, brittle, and sparse; oral mucosa appears pale, with uremic fetor (ammonia-like breath odor).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>CKD poses a risk for bleeding as well as thrombosis (Option A):</strong> Chronic kidney disease leads to platelet dysfunction (uremia-induced), causing bleeding, while proteinuria and dysregulated coagulation factors increase thrombotic risk, so both bleeding and thrombosis are recognised complications.</p>\n<p><strong>Uremic peripheral neuropathy occurs in stage 4 CKD (Option B):</strong> Uremic neuropathy typically develops in advanced CKD (stage 4 or beyond), often presenting as a distal, symmetrical, sensorimotor neuropathy predominantly affecting the lower limbs.</p>\n<p><strong>Glucose metabolism is impaired in CKD (Option C): </strong>CKD leads to insulin resistance and glucose intolerance, especially in moderate to advanced stages, although it often doesn't require specific treatment unless overt diabetes is present.</p>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs are used in CKD to reduce the intraglomerular pressure and proteinuria?<br>1. ACEI<br>2. ARB<br>3. Non dihydropyridine CCBs<br>4. Beta blockers</span></p>",
      "unique_key": "DT1219947",
      "question_audio": null,
      "question_video": null,
      "map_id": 1219947,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>ACEIs and ARBs</strong> lower intraglomerular pressure by dilating the efferent arteriole, reducing proteinuria.</li>\n<li><strong>Non-dihydropyridine CCBs</strong> (like verapamil, diltiazem) also have antiproteinuric effects.</li>\n<li><strong>Beta blockers</strong> control BP but do not reduce intraglomerular pressure or proteinuria.</li>\n</ul>\n<p><strong>ACE inhibitors (ACEI):</strong></p>\n<ul>\n<li><strong>Mechanism:</strong> Dilate efferent arterioles &rarr; reduce glomerular capillary pressure</li>\n<li><strong>Effect:</strong> &darr; Proteinuria, &darr; GFR decline</li>\n<li><strong>Used in CKD and diabetic nephropathy</strong></li>\n</ul>\n<p><strong>Angiotensin receptor blockers (ARB):</strong></p>\n<ul>\n<li><strong>Mechanism:</strong> Similar to ACEI, but blocks angiotensin II receptor</li>\n<li><strong>Effect:</strong> &darr; Intraglomerular pressure, &darr; Proteinuria</li>\n<li>Alternative in <strong>ACEI-intolerant patients</strong></li>\n</ul>\n<p><strong>Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem)</strong></p>\n<ul>\n<li><strong>Mechanism:</strong> Reduce proteinuria independently of BP-lowering effect</li>\n<li><strong>Additional benefit:</strong> Especially in diabetics, when RAS blockers are insufficient</li>\n<li><strong>Note:</strong> Dihydropyridine CCBs (e.g., amlodipine) <strong>do not</strong> reduce proteinuria.</li>\n</ul>\n<p><strong>Beta-blockers:</strong></p>\n<ul>\n<li><strong>Mechanism:</strong> Primarily reduces systemic BP and heart rate</li>\n<li><strong>Effect:</strong> <strong>No direct effect</strong> on intraglomerular pressure or proteinuria</li>\n<li><strong>Used for cardiovascular protection</strong>, not for nephroprotection directly.</li>\n</ul>",
      "correct_choice_id": 301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}